Although more studies of the effects of CD39 expression on Treg CD39high cells in CRC are needed, these data indicate that this is an important regulator of immunosuppression in the TME, with the ability to reduce T effector cell migration into the tumor. This evidence concerns the gene ENTPD1 and colorectal carcinoma.